What is the recommended protocol for weaning off Xanax (alprazolam)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Protocol for Weaning Off Xanax (Alprazolam)

The recommended protocol for weaning off Xanax (alprazolam) is to reduce the dose gradually by no more than 0.5 mg every three days to minimize withdrawal symptoms and prevent complications. 1

Understanding Alprazolam Withdrawal

  • Alprazolam is a high-potency benzodiazepine with a relatively short half-life, making it particularly prone to causing withdrawal symptoms when discontinued abruptly 1
  • Withdrawal symptoms can range from mild dysphoria and insomnia to a major syndrome including abdominal and muscle cramps, vomiting, sweating, tremors, and seizures 1
  • The risk of withdrawal seizures may be increased at doses above 4 mg/day 1
  • Signs and symptoms of withdrawal are often more prominent after rapid decrease of dosage or abrupt discontinuation 1

Recommended Tapering Protocol

General Approach

  • Never discontinue alprazolam abruptly due to risk of withdrawal seizures 1
  • Reduce the daily dosage by no more than 0.5 mg every three days 1
  • For patients on higher doses or extended treatment periods, an even slower taper may be beneficial 1

Specific Tapering Schedules Based on Usage Duration

For Short-Term or Low-Dose Use:

  • Gradual tapering over approximately 4 weeks on an outpatient basis 2
  • Reduce by approximately 10-20% of the original dose every 1-2 weeks 2

For Long-Term or High-Dose Use:

  • More gradual tapering is recommended, potentially over several months 1
  • Consider a 10% reduction of the current dose every 1-2 weeks 3
  • For patients taking more than 4 mg daily, initial reductions may be larger, then slow the taper as the dose becomes lower 1

Monitoring During Withdrawal

  • Closely monitor for withdrawal symptoms during the tapering process 1
  • Common withdrawal symptoms to watch for include:
    • Insomnia (29.5% of patients) 1
    • Anxiety (19.2%) 1
    • Light-headedness (19.3%) 1
    • Fatigue and tiredness (18.4%) 1
    • Abnormal involuntary movements (17.3%) 1
    • Headache (17.0%) 1
    • Nausea/vomiting (16.5%) 1
    • Sweating (14.4%) 1

Managing Withdrawal Symptoms

  • If severe withdrawal symptoms occur, consider temporarily maintaining the current dose before continuing the taper 1
  • For significant anxiety or insomnia during tapering:
    • Consider adjunctive medications such as hydroxyzine for anxiety or trazodone for sleep 4
    • Non-pharmacological interventions like relaxation techniques may be helpful 4

Special Considerations

  • For elderly patients or those with debilitating conditions, use an even more gradual tapering schedule 1
  • Patients with a history of seizures require especially careful monitoring during withdrawal 1
  • Addiction-prone individuals should be under careful surveillance during the tapering process 1
  • Some patients may benefit from switching to a longer-acting benzodiazepine like diazepam or chlordiazepoxide before tapering 5

Alternative Approach: Substitution Method

  • For difficult cases, some clinicians substitute a longer-acting benzodiazepine like chlordiazepoxide:
    • Substitute approximately 50 mg of chlordiazepoxide for each 1 mg of alprazolam (may need adjustment for elderly patients) 5
    • Then taper the chlordiazepoxide by approximately 10% each day over a 7-14 day period 5
    • This approach may be more suitable for inpatient settings 5

Pitfalls to Avoid

  • Avoid tapering too quickly, which increases risk of withdrawal symptoms and seizures 1
  • Don't underestimate psychological dependence, especially in patients who have taken alprazolam for extended periods 1
  • Be aware that some patients may experience "rebound anxiety" that can be mistaken for recurrence of the original condition 1
  • Recognize that some patients may require multiple attempts at tapering before successfully discontinuing alprazolam 3

References

Research

Detoxification from benzodiazepines: schedules and strategies.

Journal of substance abuse treatment, 1991

Research

Discontinuation of alprazolam treatment in panic patients.

The American journal of psychiatry, 1987

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.